Africa is experiencing a sharp rise in mpox cases, with nearly 4,000 reported in the past week, according to the continent’s public health body. Dr. Jean Kaseya, head of the Africa Centers for Disease Control and Prevention (Africa CDC), shared this update during an online briefing on Tuesday.
In the past week, Africa reported 81 mpox-related deaths, bringing the totals to 22,863 cases and 622 deaths. Despite promises of 380,000 doses of mpox vaccines from Western partners like the European Union and the United States, this amounts to less than 15% of what is needed to control the outbreaks, particularly in Congo, the epicenter of the global health emergency.
The first batch of promised vaccines for Congo, including 50,000 doses from the U.S. and 15,000 from the GAVI vaccines alliance, is now expected to arrive on September 1 after delays related to documentation and emergency authorization.
Congo has also requested at least 2 million additional doses from Japan, with negotiations reportedly advanced. The new mpox variant, first identified in Congo, is causing significant community transmission elsewhere, including nearly 800 cases in neighboring Burundi over the last month.
The U.S. has donated 10,000 doses of mpox vaccines to Nigeria, marking the first known donation to Africa since the current outbreaks began. Nigeria has recorded 40 mpox cases this year.
The Africa CDC is developing a unified response plan for the outbreaks, which will be presented to African heads of state in September. Meanwhile, health measures and hygiene practices are being promoted across Africa to slow the virus’s spread, though enforcing these measures is challenging in Congo’s displaced camps amidst ongoing humanitarian crises.